Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can resilience defeat HIV stigma? a new study investigates

NCT ID NCT05149001

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This study looks at how psychological and social factors might help people living with HIV resist self-stigma—the negative feelings and beliefs they may hold about themselves due to their condition. Researchers will survey both patients and their healthcare providers to understand what contributes to resilience. The goal is to uncover insights that could lead to better support and interventions for those affected.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this research could identify key factors that protect people living with HIV from self-stigma, leading to better psychological support and interventions.
What could go wrong
This is an observational study, so it cannot prove cause and effect. The findings may not apply to all populations or settings, and self-stigma is complex with many influences.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

667 people

The number who actually took part.

Started

Jan 2022

Finished

Apr 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

people living with HIV

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * For patients: adult patient, male or female, infected with HIV medically monitored in a hospital department involved in the investigation. * Affiliation to a Social Security scheme For caregivers:Caregiver caring for people living with HIV as part of a hospital service involved in the survey (doctor, IDE, psychologist, other ...). Exclusion Criteria: * Minor patient * Refusal of participation * Persons under guardianship, guardianship or legal protection

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV infections are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CH Annecy Genevois

    Annecy, France

  • CH Cholet

    Cholet, France

  • CH Morlaix

    Morlaix, France

  • CH Moulins-Yzeure

    Moulins, France

  • CH NIORT

    Niort, France

  • CH Orléans

    Orléans, France

  • CH Perpignan

    Perpignan, France

  • CH VICHY

    Vichy, France

  • CH de Versailles

    Le Chesnay, France

  • CHBA Vannes

    Vannes, France

  • CHD Vendrée

    La Roche-sur-Yon, France

  • CHRU Brest

    Brest, France

  • CHU Felix Guyon

    Saint-Denis, Reunion

  • CHU LYON

    Lyon, France

  • CHU NICE

    Nice, France

  • CHU Nord

    Saint-Etienne, France

  • CHU Pointe-à-Pitre

    Pointe-à-Pitre, Guadeloupe

  • CHU Poitiers

    Poitiers, France

  • CHU Strasbourg

    Strasbourg, France

  • CHU de Mulhouse

    Mulhouse, France

  • CISIH

    Marseille, France

  • Centre Hospitalier Bretagne Sud

    Lorient, France

  • Centre Hospitalier Intercommunal de Cornouaille

    Quimper, France

  • Centre Hospitalier du Pays d'Aix

    Aix-en-Provence, France

  • Ch Le Mans

    Le Mans, France

  • Ch Montlucon

    Montluçon, France

  • Ch Valenciennes

    Valenciennes, France

  • Chru Besancon

    Besançon, France

  • Chu Angers

    Angers, France

  • Chu Dijon

    Dijon, France

  • Chu Nantes

    Nantes, France

  • Chu Poissy

    Poissy, France

  • Chu Reims

    Reims, France

  • Chu Toulon

    Toulon, France

  • Clermont-Ferrand University Hospital

    Clermont-Ferrand, France

  • Groupe Hospitalier de La rochelle-Ré-Aunis

    La Rochelle, France

  • Hopital Antoine Beclere

    Clamart, France

  • Hopital Bicetre Aphp

    Le Kremlin-Bicêtre, France

  • Hopital Raymond Poincaré

    Garches, France

  • Hopital Tenon

    Thenon, France

  • Hopitel Necker

    Paris, France

  • Hôpital Nord Ouest villefranche sur Saone

    Villefranche-sur-Saône, France

  • Pole Santé Publique - CH Laennec

    Quimper, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.